Skip to main content
TipRanks
Go Ultimate75% OFF

Krystal Biotech (KRYS) Financial Statements

736 Followers

Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently $9.05B. The company's EPS TTM is $7.66; its P/E ratio is 39.85; Krystal Biotech is estimated to report earnings on March 1, 2027, and the estimated EPS forecast is $2.04. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 389.13M$ 290.51M$ 50.70M$ 0.00$ 0.00
Gross Profit$ 360.36M$ 270.45M$ 47.60M$ 0.00$ 0.00
Operating Income$ 161.29M$ 65.69M$ -109.73M$ -145.20M$ -68.28M
EBITDA$ 196.02M$ 109.91M$ -92.22M$ -116.14M$ -65.31M
Net Income$ 204.83M$ 89.16M$ 10.93M$ -139.97M$ -69.57M
Balance Sheet
Cash & Short-Term Investments$ 827.79M$ 597.52M$ 532.18M$ 379.17M$ 438.10M
Total Assets$ 1.33B$ 1.06B$ 818.36M$ 558.45M$ 626.29M
Total Debt$ 9.34M$ 7.26M$ 8.09M$ 8.93M$ 8.02M
Net Debt$ -486.96M$ -337.60M$ -350.23M$ -152.97M$ -333.22M
Total Liabilities$ 114.23M$ 109.46M$ 39.71M$ 36.22M$ 32.72M
Stockholders' Equity$ 1.22B$ 946.38M$ 778.64M$ 522.23M$ 593.58M
Cash Flow
Free Cash Flow$ 188.91M$ 119.18M$ -100.60M$ -153.55M$ -116.27M
Operating Cash Flow$ 200.87M$ 123.42M$ -88.80M$ -100.57M$ -47.94M
Investing Cash Flow$ -58.42M$ -163.44M$ 82.64M$ -114.08M$ -226.77M
Financing Cash Flow$ 8.71M$ 27.01M$ 202.75M$ 35.35M$ 347.69M

Currency in USD

Krystal Biotech Earnings and Revenue History

-250M0250M500M-1200 %-600 %0 %600 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Krystal Biotech Liabilities to Assets

0500M1B1.5B0 %4 %8 %12 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Krystal Biotech Cash Flow

-300M-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing

Krystal Biotech Forecast EPS vs Actual EPS

0.511.522.53Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss